figures, the statistical analysis showed a significant
difference in this band too.
Looking at the data points as a function of time,
there is no visual trend that implies that the
distribution should change over time. For both
subjects, the variance in the θ-band is higher during
night recordings, but both the mean and the standard
deviation are consistent over time.
4 DISCUSSION
4.1 Data Quality
In a previous publication we showed that the EEG
data quality of subcutaneous measurements made 10
days after implantation of the implantable device is
comparable to the data quality of standard scalp
EEG (Duun-Henriksen et al., 2015). The present
analysis has shown that the 20
th percentile of the
average power in the five standard frequency bands
do not change over a time course of ~ 1 month. This
indicates that the good data quality documented ten
days after implantation can be expected throughout
the ultra-long term, subcutaneous EEG
measurement.
4.1.1 20th Percentile
The use of the 20th percentile as a measure of the
approximate power during a 30 min long period has
some advantages as well as pitfalls. The advantage is
that especially during day, a decent amount of
artefacts are seen. Extracting the 20
th percentile
eliminates those artefacts. Investigating the amount
of artefacts in data was out of the scope of this
extended abstract, but the number is well above the
20
th percentile. The pitfall is that data are not
stationary, thus eliminating states that are evident for
less than 20% of the time. Such a state is for
example the deep sleep stage 3 with pronounced
high amplitudes of delta sleep. As this state only
constitutes approximately 15% of the time for
normal adults during sleep, this will not be included
in the 20
th percentile. This is probably also the
reason that the power in the delta-band is actually
higher during day recordings than night recordings
in this comparison.
4.1.2 Beta-power Declines during Night
It was seen that for both βlow, and βhigh frequency
bands the power was significantly lower during
night recordings. Whether this is due to less β-
activity during the night or simply less muscle
activity during the day is impossible to say with the
current analysis. Further investigation is needed.
4.2 The Use of the Device for BCI
We believe that the results support the statement that
the novel device is feasible for ultra-long term EEG
monitor that can be used for applications within BCI
technologies where continuous and instantaneous
measurements of the EEG is needed.
ACKNOWLEDGEMENTS
We would like to thank The Danish Council for
Strategic Research for funding of research leading to
this paper.
DECLARATION OF INTEREST
Jonas Duun-Henriksen and Sirin W. Gangstad are
full time employed at Hypo-Safe A/S developing
and producing devices for unobtrusive subcutaneous
EEG monitoring.
REFERENCES
Brunner, C., Birbaumer, N., Blankertz, B., Guger, C.,
Kübler, A., Mattia, D., … Müller-Putz, G. R. (2015).
BNCI Horizon 2020: towards a roadmap for the BCI
community. Brain-Computer Interfaces, 1–10.
doi:10.1080/2326263X.2015.1008956
Casson, A. J., Yates, D. C., Smith, S. J. M., Duncan, J. S.,
& Rodriguez-Villegas, E. (2010). Wearable
electroencephalography. IEEE Engineering in
Medicine and Biology Magazine, 29(3), 44–56.
doi:10.1109/MEMB.2010.936545
Duun-Henriksen, J., Kjaer, T., Sørensen, J., & Juhl, C.
(2015). Ultra-long term subcutaneous recording
system for EEG surveillance. In The 15th European
Congress on Clinical Neurophysiology (p. In press).
Duun-Henriksen, J., Kjaer, T. W., Looney, D., Atkins, M.
D., Sørensen, J. A., Rose, M., … Juhl, C. B. (2015).
EEG Signal Quality of a Subcutaneous Recording
System Compared to Standard Surface Electrodes.
Journal of Sensors, 2015, 1–9. doi:10.1155/2015/
341208
Elsborg, R., Remvig, L., Beck-Nielsen, H., & Juhl, C.
(2011). Detecting hypoglycemia by using the brain as
a biosensor. In P. A. Serra (Ed.), Biosensors for
Health, Environment and Biosecurity (1st ed., pp.
273–292). Rijeka: InTech. doi:10.5772/17018